Clinical trial
Effects of Citalopram on Hostility and CHD Risk
NCT00217828 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00217828 |
|---|---|
| Title | Effects of Citalopram on Hostility and CHD Risk |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cardiovascular Diseases, Heart Diseases |
| Intervention type | Drug |
| Interventions | citalopram |
| Start date | Mar 1, 2002 |
| Primary completion | Feb 1, 2003 |
| Completion | Feb 1, 2003 |
| First posted | Sep 22, 2005 |
| Last update posted | Jun 11, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: